Abstract：
OBJECTIVE: To review long-term outcomes of circumscribed choroidal hemangioma (CCH).
METHODS: Hospital charts of all CCH cases diagnosed from 2008 to 2019 were retrospectively reviewed.
RESULTS: All 172 patients were managed with either observation, transpupillary thermotherapy, argon laser photocoagulation, photodynamic therapy, plaque brachytherapy or stereotactic radiosurgery. The most common 3 modes of management were clinical observation (30.2%), transpupillary thermotherapy (52.9%) and argon laser photocoagulation (8.7%). Median follow-up time was 10 months (range: 3, 160). Anatomical outcomes were stable in 87.1% of observation group and improved in 60.5% of thermotherapy group. Quantified optical coherence tomography angiography findings showed statistical differences in vascular and perfusion densities in fellow eyes of hemangioma patients.
CONCLUSIONS: Circumscribed choroidal hemangioma can be treated in various ways. Transpupillary thermotherapy is an anatomically effective treatment in selected cases. The diagnosis of CCH may have vascular implications in fellow eyes of the patients.
METHODS: Hospital charts of all CCH cases diagnosed from 2008 to 2019 were retrospectively reviewed.
RESULTS: All 172 patients were managed with either observation, transpupillary thermotherapy, argon laser photocoagulation, photodynamic therapy, plaque brachytherapy or stereotactic radiosurgery. The most common 3 modes of management were clinical observation (30.2%), transpupillary thermotherapy (52.9%) and argon laser photocoagulation (8.7%). Median follow-up time was 10 months (range: 3, 160). Anatomical outcomes were stable in 87.1% of observation group and improved in 60.5% of thermotherapy group. Quantified optical coherence tomography angiography findings showed statistical differences in vascular and perfusion densities in fellow eyes of hemangioma patients.
CONCLUSIONS: Circumscribed choroidal hemangioma can be treated in various ways. Transpupillary thermotherapy is an anatomically effective treatment in selected cases. The diagnosis of CCH may have vascular implications in fellow eyes of the patients.
摘要：
目的：回顾局限性脉络膜血管瘤（CCH）的长期结果。
方法：回顾性分析2008年至2019年诊断的所有CCH病例的医院图。
结果：所有172例患者均接受任一观察，经瞳孔热疗，氩激光光凝,光动力疗法,斑块近距离放射治疗或立体定向放射外科。最常见的3种管理模式是临床观察（30.2%），经瞳孔热疗(52.9%)和氩激光光凝(8.7%)。中位随访时间为10个月（范围：3、160）。观察组的解剖结果稳定为87.1%，热疗组的改善为60.5%。量化的光学相干断层扫描血管造影结果显示，血管瘤患者的双眼血管密度和灌注密度存在统计学差异。
结论：脉络膜血管瘤的治疗方法多种多样。在某些情况下，经瞳孔热疗是解剖学上有效的治疗方法。CCH的诊断可能对患者的眼睛有血管影响。
方法：回顾性分析2008年至2019年诊断的所有CCH病例的医院图。
结果：所有172例患者均接受任一观察，经瞳孔热疗，氩激光光凝,光动力疗法,斑块近距离放射治疗或立体定向放射外科。最常见的3种管理模式是临床观察（30.2%），经瞳孔热疗(52.9%)和氩激光光凝(8.7%)。中位随访时间为10个月（范围：3、160）。观察组的解剖结果稳定为87.1%，热疗组的改善为60.5%。量化的光学相干断层扫描血管造影结果显示，血管瘤患者的双眼血管密度和灌注密度存在统计学差异。
结论：脉络膜血管瘤的治疗方法多种多样。在某些情况下，经瞳孔热疗是解剖学上有效的治疗方法。CCH的诊断可能对患者的眼睛有血管影响。
